A further study of the effect of propranolol on the blockade of alpha adrenergic receptors.
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D000818:Animals; D002415:Cats; D004837:Epinephrine / Q000494:pharmacology*; D007545:Isoproterenol / Q000494:pharmacology*; D010109:Oxymetazoline / Q000037:antagonists & inhibitors; D010643:Phenoxybenzamine / Q000037:antagonists & inhibitors*; D011433:Propranolol / Q000494:pharmacology*; D013565:Sympatholytics
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D013565:Sympatholytics; D010643:Phenoxybenzamine; D010109:Oxymetazoline; D011433:Propranolol; D007545:Isoproterenol; D004837:Epinephrine